focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 119.00
Bid: 114.50
Ask: 119.50
Change: 0.00 (0.00%)
Spread: 5.00 (4.367%)
Open: 119.00
High: 0.00
Low: 0.00
Prev. Close: 119.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Xaar plc - Commercial partnership with Quantica

5 Jul 2023 09:00

RNS Number : 9635E
Xaar PLC
05 July 2023
 

5 July 2023

 

Xaar plc

 

Commercial partnership with Quantica

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, and Quantica GmbH ("Quantica"), the multi-material 3D printing firm, have signed an exclusive commercial partnership to manufacture Quantica's NovoJet printheads, enabling ultra high viscosity printing for 2D and 3D printing applications. This partnership combines Xaar's expertise in inkjet printhead manufacturing with Quantica's ultra high viscosity printhead technology.

 

Manufacturing will take place at Xaar's high-tech facility in Huntingdon, with both companies expecting the initial NovoJet printheads to be shipping in Quantica's first 3D printers from the end of 2023. 

 

The agreement also gives Xaar commercial access to Quantica's IP in the jetting of highly viscous materials at up to 400cP at jetting temperature. This will complement Xaar's existing printheads and ImagineX technology portfolio which already enable jetting up to 100cP - far beyond other printheads available today.

 

Xaar will now offer the widest capability in printing high-performance materials to its OEM customers, meeting the opportunities for advanced manufacturing applications across electronics, display, industrial coating, adhesive and life-science sectors.

 

Founded in 2018 in Berlin, Quantica has dedicated its research and development efforts to both the novel NovoJet printhead technology and advanced multi-material 3D printers. By partnering with Xaar, a leader in inkjet printhead manufacturing, Quantica will further focus on the development of its 3D printing systems for applications in dental, medical, electronics, R&D, and more.

 

Graham Tweedale, Xaar's Chief Operation Officer, said:

 

"As we continue to accelerate our strategy the combination of our existing ImagineX technologies with the capability offered by Quantica's IP will ensure Xaar offers the widest range of solutions in jetting highly viscous materials."

 

Ramon Borrell, Chief Technology Officer for Quantica, said:

 

"Xaar is widely recognised for the quality of its printheads, and this agreement enables us to focus on delivering the roadmap of innovative NovoJet 3D printers for high performance multi-material parts with full confidence the printheads will deliver for our customers and partners."

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEZLFBXDLEBBF
Date   Source Headline
2nd Jan 201510:00 amRNSTotal Voting Rights
19th Dec 20142:34 pmRNSHolding(s) in Company
17th Dec 20147:00 amRNSTrading Update
16th Dec 20143:58 pmRNSHolding(s) in Company
15th Dec 201411:01 amRNSHolding(s) in Company
12th Dec 20149:31 amRNSHolding(s) in Company
1st Dec 20145:32 pmRNSTotal Voting Rights
27th Nov 20144:22 pmRNSHolding(s) in Company
3rd Nov 201412:34 pmRNSTotal Voting Rights
3rd Nov 201410:01 amRNSHolding(s) in Company
27th Oct 201412:48 pmRNSDirector/PDMR Shareholding
10th Oct 20149:57 amRNSHolding(s) in Company
7th Oct 20144:26 pmRNSHolding(s) in Company
6th Oct 20142:35 pmRNSHolding(s) in Company
3rd Oct 20145:12 pmRNSHolding(s) in Company
2nd Oct 20147:00 amRNSInterim Management Statement
1st Oct 20143:57 pmRNSTotal Voting Rights
30th Sep 20149:12 amRNSGrant of Options - Share Save
16th Sep 20142:56 pmRNSHolding(s) in Company
9th Sep 20143:11 pmRNSHolding(s) in Company
8th Sep 20143:02 pmRNSDirector/PDMR Shareholding
1st Sep 20145:41 pmRNSTotal Voting Rights
28th Aug 20147:00 amRNS2014 Interim Results
1st Aug 20141:11 pmRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Statement
4th Jul 20143:06 pmRNSHolding(s) in Company
4th Jul 20143:01 pmRNSHolding(s) in Company
3rd Jul 20149:41 amRNSHolding(s) in Company
1st Jul 201410:38 amRNSTotal Voting Rights
1st Jul 201410:38 amRNSBlocklisting Interim Review
27th Jun 201411:31 amRNSHolding(s) in Company
25th Jun 20145:53 pmRNSHolding(s) in Company
25th Jun 20147:00 amRNSDirector/PDMR Shareholding
24th Jun 20145:05 pmRNSDirector/PDMR Shareholding
20th Jun 20144:13 pmRNSHolding(s) in Company
20th Jun 201410:36 amRNSHolding(s) in Company
20th Jun 201410:19 amRNSHolding(s) in Company
17th Jun 20147:00 amRNSTrading Update
13th Jun 20147:00 amRNSAppointment of Corporate Broker
2nd Jun 20144:00 pmRNSTotal Voting Rights
14th May 20146:10 pmRNSResult of AGM
13th May 20147:00 amRNSGrant of Options
12th May 20145:58 pmRNSDirector/PDMR Shareholding
1st May 201412:10 pmRNSTotal Voting Rights
30th Apr 201411:35 amRNSDirector/PDMR Shareholding
24th Apr 20147:00 amRNSDirector/PDMR Shareholding
23rd Apr 201410:08 amRNSNotice of 2014 AGM & Annual Financial Report
22nd Apr 20144:31 pmRNSDirector/PDMR Shareholding
17th Apr 201412:39 pmRNSDirector/PDMR Shareholding - Replacement
17th Apr 201412:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.